HonCode

Go Back   HER2 Support Group Forums > Search Forums
Register Gallery FAQ Members List Calendar Today's Posts

Showing results 251 to 275 of 500
Search took 0.26 seconds; generated 72 minute(s) ago.
Search: Posts Made By: tousled1
Forum: Herceptin / Tykerb 12-16-2007, 08:42 AM
Replies: 15
Views: 3,130
Posted By tousled1
Donna, Sorry to hear about your...

Donna,

Sorry to hear about your progression. I'm on Taxol/Carboplatin/Herceptin for lung mets. My last scan showed some improvement. Side effect I'm having is severely dropping of counts. ...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 05:08 AM
Replies: 0
Views: 1,925
Posted By tousled1
Agent Aims at Restoring Hormone-Sensitive Status of Breast Cancer Tumor Cells

SAN ANTONIO, Dec. 15 -- Breast cancer clinicians faced with tumor cells that have transformed during therapy, from hormone sensitive to insensitive, are trying to reverse the process with a lymphoma...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 05:06 AM
Replies: 2
Views: 2,500
Posted By tousled1
New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment

SAN ANTONIO, Dec. 15 /PRNewswire/ -- Denosumab is a new drug being studied to prevent fractures in breast cancer patients receiving hormonal therapy. Results of a phase 3 clinical trial using...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 05:02 AM
Replies: 0
Views: 1,744
Posted By tousled1
HERmark Presents Assay Results In Metastatic Breast Cancer

Monogram Biosciences presented the results of a study detailing the HERmark Assay's ability to identify metastatic breast cancer patients who are most likely to respond to Herceptin

full article:...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 05:01 AM
Replies: 0
Views: 3,293
Posted By tousled1
Addition of Xeloda to Herceptin and Docetaxel

San Antonio, Texas (ots/PRNewswire) - New data presented today atthe San Antonio Breast Cancer Symposium (SABCS) show that addingXeloda (capecitabine) to the current gold standard combination...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 04:58 AM
Replies: 0
Views: 1,896
Posted By tousled1
The TEACH (Tykerb Evaluation After CHemotherapy) trial

A clinical trial of a new targeted breast cancer drug, led by physicians at Massachusetts General Hospital (MGH) Cancer Center, has begun enrolling patients. The TEACH (Tykerb Evaluation After...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 04:56 AM
Replies: 0
Views: 1,682
Posted By tousled1
Herceptin Helps Women With Multiple Chromosomes Containing HER2 Gene, Study Finds

The targeted therapy Herceptin helps women with HER2+ type of breast cancer independent of whether patients have extra copies of chromosome 17, home to the HER2 gene which produces the HER2 protein...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 04:52 AM
Replies: 0
Views: 1,707
Posted By tousled1
Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit i

SAN ANTONIO, Dec. 15 /PRNewswire/ -- Interim results of the Phase II XeNA (Xeloda in NeoAdjuvant) trial suggest that the combination of oral Xeloda(R) (capecitabine) and Taxotere(R) (docetaxel),...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 04:50 AM
Replies: 0
Views: 1,901
Posted By tousled1
Breast Cancer Patients Benefit From Continued Use of Herceptin After Progression

Data presented at the 30th Annual San Antonio Breast Cancer Symposium confirm that Herceptin is the standard of care for women with HER2-positive breast cancer across all stages of the disease
...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 03:06 AM
Replies: 0
Views: 1,622
Posted By tousled1
Ten Years of Tamoxifen May Be Better than Five, but Questions Remain

Early results indicate that breast cancer survivors who take tamoxifen for longer than five years appear to have a lower rate of recurrence, although the data is still too incomplete to draw...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 03:05 AM
Replies: 0
Views: 1,839
Posted By tousled1
Targeting EGFR in Triple-Negative Breast Cancer

Breast tumors which are neither positive for ER, PR, or HER2 are colloquially referred to as triple-negative (http://www.curetoday.com/cureXtra/currentissue/archive/jan07/index.html), due to their...
Forum: Breast Cancer Meeting Highlights 12-16-2007, 03:04 AM
Replies: 0
Views: 1,654
Posted By tousled1
To Remove or Not to Remove: Scientists Report on Signs That May Guide Lymph Node Deci

A tumor's size, degree of vascular infiltration, and other distinctions may help predict whether lymph nodes need to be removed and tested, which can provide a roadmap for surgery, scientists...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 03:36 PM
Replies: 0
Views: 1,778
Posted By tousled1
Roche Says Avastin Safe in Trials With Chemotherapy (Update1)

Roche Holding AG, the world's biggest maker of cancer medicines, said its Avastin tumor-fighting drug didn't aggravate the risk of heart problems when given with standard chemotherapy to breast...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 03:34 PM
Replies: 0
Views: 2,025
Posted By tousled1
Anastrozole, marketed as Arimidex, produces better results than tamoxifen

A NEW drug for breast cancer is better than current standard treatments and can prevent the disease returning for up to eight years, the world's largest trial has found.
The study comparing two...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 03:33 PM
Replies: 0
Views: 2,066
Posted By tousled1
Stem Cells Used to Fix Breast Defects

SAN ANTONIO (AP) — For the first time, doctors have used stem cells from liposuctioned fat to fix breast defects in women who have had cancerous lumps removed.

To read full article: ...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 02:49 PM
Replies: 0
Views: 2,199
Posted By tousled1
Aromatase Inhibitor Benefit Continues After End of Treatment

Even after the end of treatment, anastrozole (Arimidex), an aromatase inhibitor, outperforms tamoxifen in women with hormone-receptor-positive early breast cancer, a researcher said...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 02:48 PM
Replies: 2
Views: 2,269
Posted By tousled1
High-Dose Chemo Gets Final Nail in Its Coffin

SAN ANTONIO, Dec. 14 -- Researchers here may have put the final nail in the coffin of a once-popular, but controversial, combination treatment for breast cancer.

To read full article:
...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 02:46 PM
Replies: 0
Views: 2,140
Posted By tousled1
Shorter Adjuvant Radiation Course Found Safe and Effective After Lumpectomy

SAN ANTONIO, Dec. 14 -- A three-week course of whole-breast irradiation after breast-conserving surgery is as effective and safe as the standard five-week program, a researcher said here

To read...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 02:43 PM
Replies: 0
Views: 2,438
Posted By tousled1
Zoledronic Acid Prevents Bone Loss during Endocrine Therapy

SAN ANTONIO, Dec. 14 -- Premenopausal breast cancer patients receiving adjuvant endocrine therapy did not suffer the substantial bone loss typically seen with such treatment when they were also given...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 02:42 PM
Replies: 0
Views: 2,179
Posted By tousled1
Docetaxel (Taxotere) Outdoes Doxorubicin (Adriamycin)

SAN ANTONIO, Dec. 14 -- An adjuvant chemotherapy regimen that substitutes docetaxel (Taxotere) for doxorubicin (Adriamycin) is more effective in early breast cancer, seven-year follow-up of a...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 02:41 PM
Replies: 0
Views: 2,350
Posted By tousled1
Benefits of Screening Mammography Extend Past Age 70

SAN ANTONIO, Dec. 14 -- Women who are 70 or older remain in the prime of life for screening mammography, researchers reported here

To read full article:...
Forum: her2group 12-15-2007, 01:40 PM
Replies: 12
Views: 1,637
Posted By tousled1
Thank you all for just being you. I'm glad I can...

Thank you all for just being you. I'm glad I can be of some assistance to you in posting the news from San Antonio. Hopefully, there will be things coming out of San Antonio that we will all...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 08:35 AM
Replies: 0
Views: 2,652
Posted By tousled1
Drugs Cut Bone Loss of Hormone Therapy

Drugs Cut Bone Loss of Hormone Therapy

Bisphosphonates Counter Side Effect of Treatment for Breast Cancer

Dec. 14, 2007 (San Antonio) -- The bone-building drugs...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 08:33 AM
Replies: 1
Views: 2,095
Posted By tousled1
male breast cancer remains below the radar.

SAN ANTONIO - <!-- START LEAD -->Two thousand Americans with breast cancer each year are not represented at the major scientific meetings on the disease. Nor do they participate in walks to raise...
Forum: Breast Cancer Meeting Highlights 12-15-2007, 08:31 AM
Replies: 2
Views: 2,740
Posted By tousled1
Amgen Bone Drug Shows Promise

Patients taking hormone blockers to fight breast cancer showed improvements in bone density when given shots of an experimental Amgen Inc. bone drug, researchers said

To read full article:...
Showing results 251 to 275 of 500

 
Forum Jump

All times are GMT -7. The time now is 01:43 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter